| Synthetic strategies and pharmacological activities of chromene and its derivatives: An overview MK Katiyar, GK Dhakad, S Arora, S Bhagat, T Arora, R Kumar Journal of Molecular Structure 1263, 133012, 2022 | 29 | 2022 |
| PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy JM Kelm, DS Pandey, E Malin, H Kansou, S Arora, R Kumar, NS Gavande Molecular Cancer 22 (1), 62, 2023 | 26 | 2023 |
| Anticancer potential of some imidazole and fused imidazole derivatives: Exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition S Kalra, G Joshi, M Kumar, S Arora, H Kaur, S Singh, A Munshi, R Kumar RSC Medicinal Chemistry 11 (8), 923-939, 2020 | 20 | 2020 |
| Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment M Kumar, G Joshi, S Arora, T Singh, S Biswas, N Sharma, ZR Bhat, ... Molecules 26 (5), 1490, 2021 | 17 | 2021 |
| Synthesis of 1, 4-dihydropyrazolo [4, 3-b] indoles via intramolecular C (sp2)-N bond formation involving nitrene insertion, DFT study and their anticancer assessment M Kaur, V Mehta, AA Wani, S Arora, PV Bharatam, A Sharon, S Singh, ... Bioorganic Chemistry 114, 105114, 2021 | 16 | 2021 |
| Knoevenagel/tandem knoevenagel and michael adducts of cyclohexane-1, 3-dione and aryl aldehydes: synthesis, DFT studies, xanthine oxidase inhibitory potential, and molecular … S Arora, G Joshi, S Kalra, AA Wani, PV Bharatam, P Kumar, R Kumar ACS omega 4 (3), 4604-4614, 2019 | 15 | 2019 |
| A perspective on medicinal chemistry approaches for targeting pyruvate kinase M2 S Arora, G Joshi, A Chaturvedi, M Heuser, S Patil, R Kumar Journal of Medicinal Chemistry 65 (2), 1171-1205, 2021 | 12 | 2021 |
| Targeting the epidermal growth factor receptor with molecular degraders: State-of-the-art and future opportunities P Maity, J Chatterjee, KT Patil, S Arora, MK Katiyar, M Kumar, ... Journal of Medicinal Chemistry 66 (5), 3135-3172, 2023 | 9 | 2023 |
| Design, synthesis and anticancer activity of 2-arylimidazo [1, 2-a] pyridinyl-3-amines UP Yadav, AJ Ansari, S Arora, G Joshi, T Singh, H Kaur, N Dogra, ... Bioorganic Chemistry 118, 105464, 2022 | 9 | 2022 |
| Pore-forming proteins and their role in cancer and inflammation: mechanistic insights and plausible druggable targets J Sankar, S Arora, G Joshi, R Kumar Chemico-Biological Interactions 366, 110127, 2022 | 4 | 2022 |
| Design, Synthesis and Biological Evaluation of New 5‐(2‐Nitrophenyl)‐1‐aryl‐1H‐pyrazoles as Topoisomerase Inhibitors M Kaur, V Mehta, S Arora, A Munshi, S Singh, R Kumar ChemistrySelect 6 (26), 6644-6651, 2021 | 4 | 2021 |
| Rationalization of the activity profile of pyruvate kinase isozyme m2 (pkm2) inhibitors using 3d qsar M Kusuma, S Arora, S Kalra, A Chaturvedi, M Heuser, R Kumar Current Topics in Medicinal Chemistry 21 (25), 2258-2271, 2021 | 2 | 2021 |
| FDA approved six-membered ring fused pyrimidine-based derivatives S Arora, R Kumar Fused Pyrimidine-Based Drug Discovery, 221-248, 2023 | 1 | 2023 |
| The Future of COVID-19 Treatment S Arora, M Kumar, G Joshi, R Kumar COVID-19: Diagnosis and Management-Part II, 169, 2021 | | 2021 |
Raj Kumar, FRSCProfessor of Medicinal/Pharmaceutical Chemistry, Central University of PunjabE-mail megerősítve itt: cup.edu.in
